Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience

Granulocyte transfusions are a relatively safe adjunctive therapeutic option for patients with chronic granulomatous disease and severe/refractory bacterial or fungal infections. Early initiation, high frequency and sustained therapy is associated with significantly better outcomes.

Guardado en:
Detalles Bibliográficos
Publicado en:J Allergy Clin Immunol
Autores principales: Marciano, Beatriz E., Allen, Elisabeth S., Cantilena, Cathy C., Kristosturyan, Ervand, Klein, Harvey G., Fleisher, Thomas A., Holland, Steven M., Malech, Harry L., Rosenzweig, Sergio D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546986/
https://ncbi.nlm.nih.gov/pubmed/28342916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.02.026
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares